A TEAM from the University of the Philippines-Manila said that lagundi helps ease symptoms of Covid19 for those with mild cases.

The team released the result of its clinical trial in October, showing that lagundi tablets eased some symptoms in those with mild Covid19 cases without comorbidities.

Team leader Dr. Cecilia Maramba-Lazarte advised the public to follow the prescribed dosage.

“Adult patients may take the 600-milligram tablet or 5 milliliters of the 600-mg syrup thrice daily. Meanwhile, the dosage requirement for pediatric patients would vary, depending on their age range. The 300-mg syrup may be taken thrice daily by children, following the suggested dosage per intake: 2.5-5 mL for ages two to four, 5 mL for ages four to six and 7.5-10 mL for ages six to 12,” Science and Technology Secretary Fortunato Dela Peña said.

“Teens aged 12 and older may also take the 600-mg tablet thrice a day. Following these guidelines, the use of the medicine may alleviate mild Covid-19 symptoms, especially the loss of sense of smell for patients,” he added.

The DOST chief said that lagundi was included in the Philippine Health Insurance Corp.’s homecare kit for mild Covid19 patients.